Navigation Links
BrainScope(TM) Receives FDA Clearance for Portable EEG Device
Date:8/11/2009

WASHINGTON, Aug. 11 /PRNewswire/ -- BrainScope Company, Inc today announced its first device, the ZOOM-100DC brain electrical activity data collection system, has been cleared for marketing by the U.S. Food and Drug Administration under section 510(k) of the FD&C Act. The ZOOM-100DC is an advanced 8-channel, portable, handheld electroencephalogram (EEG) device capable of recording and displaying EEG waveforms and providing conventional EEG measures displayed in tables.

The ZOOM-100DC is designed to be used at the initial point of care where traditional EEG tools are not readily available. The ZOOM-100DC is intended to monitor the state of the brain by acquisition and display of electroencephalogram (EEG) signals and by the calculation of standard quantitative EEG (qEEG) parameters. The ZOOM-100DC is a prescription use device.

The ZOOM-100DC device has the following functional features:

  • Portable
  • Battery Operated
  • 8 single ended channels, (5 differential channels viewable concurrently)
  • Automated artifact detection system ensures that EEG measures are derived from "clean" EEG signals.
  • Spectral averaging and display of power spectra
  • Conventional EEG measures displayed in Tables
  • Pre-test electrode impedance check
  • Ergonomic touch-screen user-interface with easy to read displays
  • Raw EEG waveforms displayed in real-time and playback mode
  • Compact Flash storage of digitized raw waveforms and processed results

"We are delighted that the ZOOM-100DC has received FDA marketing clearance. This is an important step for us as we further develop our technology platform to create a second device that is more sophisticated, robust, portable for adjunctive assessment of Traumatic Brain Injury (TBI)," said BrainScope CEO Michael Singer. "We are working hard to develop this next generation technology to provide a reliable, rapid and objective adjunctive assessment of potential TBI for use in triaging patients, particularly in the military where the need is so high."

BrainScope's novel application of advanced mathematics and miniaturized hardware is designed to bridge the limitations of traditional EEG tools, which are bulky, expensive, and require expert data interpretation, to provide easy-to-use, non-invasive and timely tools that can assist with an initial assessment of brain function as well as provide adjunctive assessment across the brain care path.

Backed by Revolution LLC (the investment arm of AOL co-founder Steve Case), ZG Ventures and Alafi Capital, BrainScope is a health technology company that is developing a new generation of hand-held, simple-to-use, non-invasive instruments designed to aid medical professionals in rapidly, accurately, and objectively assessing brain function at the initial point of care. Initially, BrainScope has focused its research and development efforts on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function.

BrainScope's future products could eventually be used for assessment of suspected TBI in soldiers, athletes and accident victims.

Additionally, BrainScope announced the launch of a website, www.brainscope.com, where more information can be found about the company and its technologies.

About BrainScope(TM)

BrainScope Company, Inc is a privately held medical neurotechnology company developing a new generation of portable, simple-to-use, non-invasive instruments to rapidly, and objectively assess brain function at the initial point of care. The portability and ease-of-use of these tools in development could aid United States military Health Service Support personnel in promptly diagnosing Traumatic Brain Injuries that require rest and/or other treatment and removal from environments at risk for repeat brain injury. The company's initial focus is the development of a device for military use, to aid in detection and assessment of Traumatic Brain Injury (including Severe Traumatic Brain Injury, Moderate Traumatic Brain Injury and Mild Traumatic Brain Injury/Concussion, all referred to as "TBI") using an objective scale.


'/>"/>
SOURCE BrainScope Company, Inc
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Integrated Medical Systems Receives $3.25 Million from the U.S. Army for Worlds First Suitcase Intensive Care Unit
2. AllMeds' EMR Receives CCHIT 2008 Certification Software Complies with 100 Percent of Certification Criteria
3. AlphaRx Receives China Patent on Its Drug Delivery Platform
4. Care to Care Receives Full URAC Health Utilization Management Accreditation
5. Covidien receives FDA clearance for its Puritan Bennett 840 ventilator system
6. Orphanage Receives Nearly $1 Million from Private Donor
7. Chesson Labs Liquid Bandage Product NUVADERM(TM) Receives FDA 510(k) Market Clearance
8. AccuVein Vein Illuminator Receives European CE Mark
9. CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
10. Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
11. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Appleton, Wis. (PRWEB) , ... February 12, 2016 ... ... its second Lean Leadership Series at Zuckerberg San Francisco General Hospital on April ... to practice new behaviors and create new habits. The workshops cover a broad ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Fisher House Foundation ... Mayor John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns ... the VA Southern Nevada Healthcare System. This will be the first Fisher House ...
(Date:2/12/2016)... ... 12, 2016 , ... Vail knee specialist Robert LaPrade, MD, PhD ... . The list consists of physicians establishing, leading and partnering with ambulatory surgery centers ... An Ambulatory Surgery Center, also known as an ASC, is a modern health care ...
(Date:2/12/2016)... ... 12, 2016 , ... Donor Network West, the organ procurement organization that heals ... with San Ramon Regional Medical Center. Under the collaboration, the first of its kind, ... accommodate a more certain time frame for donor families for the recovery of organs. ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... surrounding communities by continuing it’s commitment to act as Agents of Change in ... works closely with area homeless families to fulfill immediate needs and help them ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... 11, 2016 Stem cells are primitive cells ... self-renewal and the capacity to differentiate into mature cell ... as the first mouse embryonic stem cells were derived ... 1995 that the first culturing of embryonic stem cells ... not produced until 2006 As a result of these ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology: